Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Retraction: DNA methylation profiles of lymphoid and hematopoietic malignancies.

Takahashi T, Shivapurkar N, Reddy J, Shigematsu H, Miyajima K, Suzuki M, Toyooka S, Zöchbauer-Müller S, Drach J, Parikh G, Zheng Y, Feng Z, Kroft SH, Timmons C, McKenna RW, Gazdar AF.

Clin Cancer Res. 2013 Jan 1;19(1):307. doi: 10.1158/1078-0432.CCR-12-3679. Epub 2012 Dec 17. No abstract available.

2.

Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes.

Shivapurkar N, Takahashi T, Reddy J, Zheng Y, Stastny V, Collins R, Toyooka S, Suzuki M, Parikh G, Asplund S, Kroft SH, Timmons C, McKenna RW, Feng Z, Gazdar AF.

Cancer Res. 2004 Jun 1;64(11):3757-60.

3.

Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging.

Bocker MT, Hellwig I, Breiling A, Eckstein V, Ho AD, Lyko F.

Blood. 2011 May 12;117(19):e182-9. doi: 10.1182/blood-2011-01-331926. Epub 2011 Mar 22.

4.
5.

Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors.

Reddy J, Shivapurkar N, Takahashi T, Parikh G, Stastny V, Echebiri C, Crumrine K, Zöchbauer-Müller S, Drach J, Zheng Y, Feng Z, Kroft SH, McKenna RW, Gazdar AF.

Oncogene. 2005 Jan 20;24(4):732-6.

PMID:
15580314
6.

[Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].

Nakatsuka S, Takakuwa T, Aozasa K.

Rinsho Byori. 2001 Dec;49(12):1242-7. Review. Japanese.

PMID:
11797395
7.
8.

Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array.

Kwee I, Rinaldi A, Rancoita P, Rossi D, Capello D, Forconi F, Giuliani N, Piva R, Inghirami G, Gaidano G, Zucca E, Bertoni F.

Br J Haematol. 2012 Feb;156(3):354-7. doi: 10.1111/j.1365-2141.2011.08946.x. Epub 2011 Nov 25.

PMID:
22118580
9.

Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.

Wang LQ, Liang R, Chim CS.

Expert Rev Mol Diagn. 2012 Sep;12(7):755-65. doi: 10.1586/erm.12.64. Review.

PMID:
23153241
10.
11.

Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.

Galm O, Esteller M.

Int J Hematol. 2004 Aug;80(2):120-7. Review.

PMID:
15481439
12.

HSPB8 is methylated in hematopoietic malignancies and overexpression of HSPB8 exhibits antileukemia effect.

Cui XY, Wang N, Yang BX, Gao WF, Lin YM, Yao XR, Ma XT.

Exp Hematol. 2012 Jan;40(1):14-21. doi: 10.1016/j.exphem.2011.09.004. Epub 2011 Sep 10.

PMID:
21914495
13.

[Methylation status of CpG islands in secreted frizzled-related protein gene promoter region of malignant hematopoietic cell lines].

Xu CB, Shen JZ, Shen SF, Fu HY, Wu XM, Wu DS, Zhu YF, Chen L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Dec;17(6):1487-91. Chinese.

PMID:
20030932
14.

Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.

Strathdee G, Holyoake TL, Sim A, Parker A, Oscier DG, Melo JV, Meyer S, Eden T, Dickinson AM, Mountford JC, Jorgensen HG, Soutar R, Brown R.

Clin Cancer Res. 2007 Sep 1;13(17):5048-55.

15.

Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.

Ogawa S, Hangaishi A, Miyawaki S, Hirosawa S, Miura Y, Takeyama K, Kamada N, Ohtake S, Uike N, Shimazaki C, et al.

Blood. 1995 Aug 15;86(4):1548-56.

16.

Epigenetic immunomodulation of hematopoietic malignancies.

Gattei V, Fonsatti E, Sigalotti L, Degan M, Di Giacomo AM, Altomonte M, Calabrò L, Maio M.

Semin Oncol. 2005 Oct;32(5):503-10. Review.

PMID:
16210091
17.

[Tissue specificity of the decrease of cattle lymphocyte DNA methylation during chronic lymphoid leukemia].

Burtseva NN, Azizov IuM, Vaniushin BF.

Biokhimiia. 1979 Jul;44(7):1296-302. Russian.

PMID:
497277
18.

Gene silencing by DNA methylation in haematological malignancies.

Boultwood J, Wainscoat JS.

Br J Haematol. 2007 Jul;138(1):3-11. Epub 2007 May 9. Review.

PMID:
17489980
20.

Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype.

Li Y, Nagai H, Ohno T, Yuge M, Hatano S, Ito E, Mori N, Saito H, Kinoshita T.

Blood. 2002 Oct 1;100(7):2572-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk